Study on the binding of dicumarol to .ALPHA.1-acid glycoprotein using circular dichroism spectroscopy.
- 1 January 1988
- journal article
- research article
- Published by Pharmaceutical Society of Japan in CHEMICAL & PHARMACEUTICAL BULLETIN
- Vol. 36 (12) , 4958-4962
- https://doi.org/10.1248/cpb.36.4958
Abstract
The interaction of dicumarol with .alpha.1-acid glycoprotein (.alpha.1-AGP) was studied by circular dichroism measurements. A single site having a binding constant of 2.9 .times. 105 M-1 was capable of inducing optical activity in dicumarol. The induced ellipticity of the dicumarol-.alpha.1-AGP complex was decreased by raising the pH from 6.0 to 9.0, reflecting the changes in the molecular species of the drug and the microenvironmental changes in .alpha.1-AGP. The displacement of dicumarol from .alpha.1-AGP by fatty acids and neutral salts suggested a hydrophobic force to be involved in the binding. Interestingly, dicumarol was displaced by acidic drugs that bind to the binding site on human serum albumin called site I, or the warfarin site, whereas site II acidic drugs did not displace any dicumarol. Simple attempts to correlate displacement of dicumarol by p-aminobenzoates with the molecular size of a series of p-aminobenzoates suggested that the drug binding site is a hydrophobic cleft about 20 .ANG. in depth.This publication has 5 references indexed in Scilit:
- Auramine O as a fluorescent probe for the binding of basic drugs to human α1-acid glycoprotein (α1-AG) The development of a simple fluorometric method for the determination of α1-AG in human serumBiochemical Pharmacology, 1985
- Optical studies on the specific interaction of dipyridamole with α1-acid glycoprotein (orosomucoid)Journal of Pharmacy and Pharmacology, 1982
- Disease-induced Changes in the Plasma Binding of Basic DrugsClinical Pharmacokinetics, 1980
- Binding of Drugs by Albumin Plasma ProteinJournal of Pharmaceutical Sciences, 1977
- FURTHER CHARACTERIZATION OF SPECIFIC DRUG BINDING-SITES ON HUMAN-SERUM ALBUMIN1976